enVVeno Medical Corporation
NVNO
$3.63
$0.010.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.80% | -10.27% | -12.82% | 23.45% | 21.90% |
| Total Depreciation and Amortization | -13.48% | -8.96% | -6.52% | -1.45% | 3.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.10% | -8.61% | 5.28% | -6.35% | -29.31% |
| Change in Net Operating Assets | -309.57% | 80.88% | 180.81% | -106.13% | 162.50% |
| Cash from Operations | -13.18% | -2.65% | -1.50% | 14.35% | 30.51% |
| Capital Expenditure | -- | 0.00% | -200.00% | 33.33% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 135.55% | 50.08% | 40.04% | -43.23% | -22.03% |
| Cash from Investing | 136.62% | 50.07% | 39.93% | -43.26% | -22.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 190.58% | -1,118.78% | 6,596.12% | -97.30% | 42.77% |